Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro

被引:11
|
作者
Portapilla, Gisele Bulhoes [1 ]
Pereira, Luiz Miguel [1 ]
Bronzon da Costa, Cassia Mariana [1 ]
Providello, Maiara Voltarelli [1 ]
Sampaio Oliveira, Pedro Alexandre [1 ]
Goulart, Amanda [1 ]
Anchieta, Naira Ferreira [1 ]
Wainwright, Mark [2 ]
Leite Braga, Gilberto Ubida [1 ]
de Albuquerque, Sergio [1 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ave Cafe SN-N, BR-14040903 Ribeirao Preto, RS, Brazil
[2] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England
基金
巴西圣保罗研究基金会;
关键词
METHYLENE-BLUE; OXIDATIVE STRESS; DRUG DISCOVERY; BENZNIDAZOLE; CHEMOTHERAPY; MECHANISMS; RESISTANCE; PARASITES; EFFICACY; MALARIA;
D O I
10.1155/2019/8301569
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chagas disease is a tropical illness caused by the protozoan Trypanosoma cruzi. The disease affects populations of the Americas and has been spread to other continents due to the migration process. The disease is partially controlled by two drugs, Benznidazole and Nifurtimox. These molecules are active in the acute phase of the infection but are usually ineffective during the symptomatic chronic phase. Several research groups have developed novel candidates to control Chagas disease; however, no novel commercial formulation is available. In this article, we described the anti-T. cruzi effects of phenothiazinium dyes in amastigote and trypomastigote forms of the parasite. Methylene Blue, New Methylene Blue, Toluidine Blue O, and 1,9-Dimethyl Methylene Blue inhibited the parasite proliferation at nanomolar concentrations and also demonstrated low toxicity in host cells. Moreover, combinations of phenothiazinium dyes indicated a synergic pattern against amastigotes compared to the Benznidazole counterparts. Phenothiazinium dyes levels of reactive oxygen species (ROS) and decreased the mitochondrial potential in trypomastigotes, indicating the mechanism of action of the dyes in T. cruzi. Our article offers a basis for future strategies for the control of Chagas disease using low-cost formulations, an important point for endemic underdeveloped regions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo
    Goncalves-Santos, Elda
    Caldas, Ivo S.
    Fernandes, Valquiria A.
    Franco, Lucas L.
    Pelozo, Monica F.
    Feltrim, Fernando
    Maciel, Juliana S.
    Machado, Jose Vaz C.
    Gonsalves, Reggiani V.
    Novaes, Romulo D.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [2] Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi
    Simoes-Silva, M. R.
    Nefertiti, A. S. G.
    De Araujo, J. S.
    Batista, M. M.
    Da Silva, P. B.
    Bahia, M. T.
    Menna-Barreto, R. S.
    Pavao, B. P.
    Green, J.
    Farahat, A. A.
    Kumar, A.
    Boykin, D. W.
    Soeiro, M. N. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4701 - 4707
  • [3] Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro"
    Silva, C. F.
    Batista, Marcos Meuser
    Mota, Renata Alves
    de Souza, Elen Mello
    Stephens, Chad E.
    Som, Phanneth
    Boykin, David Wilson
    Soeiro, Maria de Nazare C.
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (12) : 1939 - 1946
  • [4] The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro
    Da Silva, Cristiane Franca
    Daliry, Anissa
    Da Silva, Patricia Bernardino
    Akay, Senol
    Banerjee, Moloy
    Farahat, Abdelbasset A.
    Fisher, Mary K.
    Hu, Laixing
    Kumar, Arvind
    Liu, Zongying
    Stephens, Chad E.
    Boykin, David W.
    Correia Soeiro, Maria De Nazare
    PARASITOLOGY, 2011, 138 (14) : 1863 - 1869
  • [5] The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
    Miguel, Danilo Ciccone
    Ferraz, Marcela Lencine
    Alves, Rosana de Oliveira
    Yokoyama-Yasunaka, Jenicer K. U.
    Torrecilhas, Ana Claudia
    Romanha, Alvaro Jose
    Uliana, Silvia R. B.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2010, 105 (07): : 945 - 948
  • [6] In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi
    Herrera, Cristina
    Vallejos, Gabriel A.
    Loaiza, Randall
    Zeledon, Rodrigo
    Urbina, Andrea
    Sepulveda-Boza, Silvia
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (07): : 980 - 985
  • [7] In vitro study of the trypanocidal activity of anilinophenanthrolines against Trypanosoma cruzi
    Zuma, Aline Araujo
    da Silva, Ramon Borges
    Garden, Simon J.
    de Souza, Wanderley
    PARASITOLOGY INTERNATIONAL, 2021, 83
  • [8] In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi
    Timm, B. L.
    Da Silva, P. B.
    Batista, M. M.
    Farahat, A. A.
    Kumar, A.
    Boykin, D. W.
    Soeiro, M. N. C.
    PARASITOLOGY, 2014, 141 (10) : 1272 - 1276
  • [9] Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
    Ferreira, Daiane Dias
    Mesquita, Juliana Tonini
    da Costa Silva, Thais Alves
    Romanelli, Maiara Maria
    Jaen Batista, Denise da Gama
    da Silva, Cristiane Franca
    Silva da Gama, Aline Nefertiti
    Neves, Bruno Junior
    Melo-Filho, Cleber Camilo
    Correia Soeiro, Maria de Nazare
    Andrade, Carolina Horta
    Tempone, Andre Gustavo
    JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2018, 24
  • [10] In vitro activity of Etanidazole against the protozoan parasite Trypanosoma cruzi
    Petray, PB
    Morilla, MJ
    Corral, RS
    Romero, EL
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2004, 99 (02): : 233 - 235